1. We have far superio drug then Qbexa .
2. US plans are normally 70/30 or 80/20..where insurance covers 80%
3. Rump will be , but once we finish Dec 2024 ( 6 months of selling) with last Qtr with 60k prescribtion ( Oct to Dec Qtr) , we have established a solid run rate..
Stock will not be under $1 , market is forward looking..
1. We have far superio drug then Qbexa .2. US plans are normally...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $640.6M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.0¢ | 34.5¢ | $1.196M | 3.408M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 531939 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 434961 | 11 |
View Market Depth
| Last trade - 13.33pm 17/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |